Polyinosinic-polycytidylic acid suppresses acetaminophen-induced hepatotoxicity independent of type I interferons and toll-like receptor 3

Hepatology

Volumn 53, Issue 6, 2011, Pages 2042-2052

  Ghaffari, Amir A ^a   Chow, Edward K ^a   Iyer, Shankar S ^a   Deng, Jane C ^b   Cheng, Genhong ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; CYTOPLASMIC RECEPTOR; DOUBLE STRANDED RNA; INTERFERON; INTERFERON RECEPTOR; PARACETAMOL; POLYINOSINIC POLYCYTIDYLIC ACID; PREGNANE X RECEPTOR; RETINOID X RECEPTOR ALPHA; TOLL LIKE RECEPTOR 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG METABOLISM; LIVER TOXICITY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; VESICULAR STOMATITIS VIRUS;

ACETAMINOPHEN; ANIMALS; ANTIVIRAL AGENTS; CYTOCHROME P-450 ENZYME SYSTEM; DRUG SYNERGISM; DRUG-INDUCED LIVER INJURY; INTERFERON TYPE I; LIVER; MALE; MICE; POLY I-C; RECEPTORS, STEROID; RETINOID X RECEPTOR ALPHA; RNA, DOUBLE-STRANDED; RNA, VIRAL; TOLL-LIKE RECEPTOR 3; XENOBIOTICS;

EID: 79957524542     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.24316     Document Type: Article

References (49)

1. Chang KC, Bell TD, Lauer BA, Chai H. Altered theophylline pharmacokinetics during acute respiratory viral illness. Lancet 1978; 1: 1132-1133.
2. McKenzie H, Parratt D, White RG. IgM and IgG antibody levels to ampicillin in patients with infectious mononucleosis. Clin Exp Immunol 1976; 26: 214-221.
3. Kokwaro GO, Ismail S, Glazier AP, Ward SA, Edwards G. Effect of malaria infection and endotoxin-induced fever on the metabolism of antipyrine and metronidazole in the rat. Biochem Pharmacol 1993; 45: 1243-1249.
4. Morgan ET. Regulation of cytochromes P450 during inflammation and infection. Drug Metab Rev 1997; 29: 1129-1188.
5. Chow EK, Castrillo A, Shahangian A, Pei L, O'Connell RM, Modlin RL, et al. A role for IRF3-dependent RXRalpha repression in hepatotoxicity associated with viral infections. J Exp Med 2006; 203: 2589-2602.
6. Pugliese A, Beltramo T, Torre D. Reye's and Reye's-like syndromes. Cell Biochem Funct 2008; 26: 741-746.
7. Berde CB, Sethna NF. Analgesics for the treatment of pain in children. N Engl J Med 2002; 347: 1094-1103.
8. Chun LJ, Tong MJ, Busuttil RW, Hiatt JR. Acetaminophen hepatotoxicity and acute liver failure. J Clin Gastroenterol 2009; 43: 342-349.
9. Zaher H, Buters JT, Ward JM, Bruno MK, Lucas AM, Stern ST, et al. Protection against acetaminophen toxicity in CYP1A2 and CYP2E1 double-null mice. Toxicol Appl Pharmacol 1998; 152: 193-199.
10. Thummel KE, Lee CA, Kunze KL, Nelson SD, Slattery JT. Oxidation of acetaminophen to N-acetyl-p-aminobenzoquinone imine by human CYP3A4. Biochem Pharmacol 1993; 45: 1563-1569.
11. Dahlin DC, Miwa GT, Lu AY, Nelson SD. N-acetyl-p-benzoquinone imine: a cytochrome P-450-mediated oxidation product of acetaminophen. Proc Natl Acad Sci U S A 1984; 81: 1327-1331.
12. Streeter AJ, Dahlin DC, Nelson SD, Baillie TA. The covalent binding of acetaminophen to protein. Evidence for cysteine residues as major sites of arylation in vitro. Chem Biol Interact 1984; 48: 349-366.
13. Honkakoski P, Negishi M. Regulation of cytochrome P450 (CYP) genes by nuclear receptors. Biochem J 2000; 347: 321-337.
14. Beigneux AP, Moser AH, Shigenaga JK, Grunfeld C, Feingold KR. Reduction in cytochrome P-450 enzyme expression is associated with repression of CAR (constitutive androstane receptor) and PXR (pregnane X receptor) in mouse liver during the acute phase response. Biochem Biophys Res Commun 2002; 293: 145-149.
15. Wolf KK, Wood SG, Hunt JA, Walton-Strong BW, Yasuda K, Lan L, et al. Role of the nuclear receptor pregnane X receptor in acetaminophen hepatotoxicity. Drug Metab Dispos 2005; 33: 1827-1836.
16. Anapolsky A, Teng S, Dixit S, Piquette-Miller M. The role of pregnane X receptor in 2-acetylaminofluorene-mediated induction of drug transport and -metabolizing enzymes in mice. Drug Metab Dispos 2006; 34: 405-409.
17. Wu Y, Zhang X, Bardag-Gorce F, Robel RCV, Aguilo J, Chen L, et al. Retinoid X receptor alpha regulates glutathione homeostasis and xenobiotic detoxification processes in mouse liver. Mol Pharmacol 2004; 65: 550-557.
18. Pichlmair A, Reis e Sousa C. Innate recognition of viruses. Immunity 2007; 27: 370-383.
19. Sakai H, Okamoto T, Kikkawa Y. Suppression of hepatic drug metabolism by the interferon inducer, polyriboinosinic acid:polyribocitidylic acid. J Pharmacol Exp Ther 1992; 263: 381-386.
20. Bleau A, Maurel P, Pichette V, Leblond F, du Souich P. Interleukin-1beta, interleukin-6, tumour necrosis factor-alpha and interferon-gamma released by a viral infection and an aseptic inflammation reduce CYP1A1, 1A2 and 3A6 expression in rabbit hepatocytes. Eur J Pharmacol 2003; 473: 197-206.
21. Takeuchi O, Akira S. Recognition of viruses by innate immunity. Immunol Rev 2007; 220: 214-224.
22. Kato H, Sato S, Yoneyama M, Yamamoto M, Uematsu S, Matsui K, et al. Cell type-specific involvement of RIG-I in antiviral response. Immunity 2005; 23: 19-28.
23. Bartolone JB, Cohen SD, Khairallah EA. Immunohistochemical localization of acetaminophen-bound liver proteins. Fundam Appl Toxicol 1989; 13: 859-862.
24. Zhang J, Huang W, Chua SS, Wei P, Moore DD. Modulation of acetaminophen-induced hepatotoxicity by the xenobiotic receptor CAR. Science 2002; 298: 422-424.
25. Dai G, Chou N, He L, Gyamfi MA, Mendy AJ, Slitt AL, et al. Retinoid X receptor alpha regulates the expression of glutathione s-transferase genes and modulates acetaminophen-glutathione conjugation in mouse liver. Mol Pharmacol 2005; 68: 1590-1596.
26. Albano E, Rundgren M, Harvison PJ, Nelson SD, Moldéus P. Mechanisms of N-acetyl-p-benzoquinone imine cytotoxicity. Mol Pharmacol 1985; 28: 306-311.
27. Guo GL, Moffit JS, Nicol CJ, Ward JM, Aleksunes LA, Slitt AL, et al. Enhanced acetaminophen toxicity by activation of the pregnane X receptor. Toxicol Sci 2004; 82: 374-380.
28. Teschke R, Stutz G, Strohmeyer G. Increased paracetamol-induced hepatotoxicity after chronic alcohol consumption. Biochem Biophys Res Commun 1979; 91: 368-374.
29. Feierman DE, Melinkov Z, Nanji AA. Induction of CYP3A by ethanol in multiple in vitro and in vivo models. Alcohol Clin Exp Res 2003; 27: 981-988.
30. Shahangian A, Chow EK, Tian X, Kang JR, Ghaffari A, Liu SY, et al. Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice. J Clin Invest 2009; 119: 1910-1920.
31. Prandota J. Important role of proinflammatory cytokines/other endogenous substances in drug-induced hepatotoxicity: depression of drug metabolism during infections/inflammation states, and genetic polymorphisms of drug-metabolizing enzymes/cytokines may markedly contribute to this pathology. Am J Ther 2005; 12: 254-261.
32. Renton KW, Dickson G. The prevention of acetaminophen-induced hepatotoxicity by the interferon inducer poly(rI. rC). Toxicol Appl Pharmacol 1984; 72: 40-45.
33. Shadley JD, Divakaran K, Munson K, Hines RN, Douglas K, McCarver DG. Identification and functional analysis of a novel human CYP2E1 far upstream enhancer. Mol Pharmacol 2007; 71: 1630-1639.
34. Ishida Y, Kondo T, Ohshima T, Fujiwara H, Iwakura Y, Mukaida N. A pivotal involvement of IFN-gamma in the pathogenesis of acetaminophen-induced acute liver injury. FASEB J 2002; 16: 1227-1236.
35. Zhai Y, Shen X, O'Connell R, Gao F, Lassman C, Busuttil RW, et al. Cutting edge: TLR4 activation mediates liver ischemia/reperfusion inflammatory response via IFN regulatory factor 3-dependent MyD88-independent pathway. J Immunol 2004; 173: 7115-7119.
36. Getachew Y, James L, Lee WM, Thiele DL, Miller BC. Susceptibility to acetaminophen (APAP) toxicity unexpectedly is decreased during acute viral hepatitis in mice. Biochem Pharmacol 2010; 79: 1363-1371.
37. Sung RS, Qin L, Bromberg JS. TNFalpha and IFNgamma induced by innate anti-adenoviral immune responses inhibit adenovirus-mediated transgene expression. Mol Ther 2001; 3: 757-767.
38. Qiu LO, Linder MW, Antonino-Green DM, Valdes R. Suppression of cytochrome P450 2E1 promoter activity by interferon-gamma and loss of response due to the -71G>T nucleotide polymorphism of the CYP2E1*7B allele. J Pharmacol Exp Ther 2004; 308: 284-288.
39. Dufour J, Clavien P. Signaling Pathways in Liver Diseases. Berlin: Springer; 2009.
40. Gu X, Ke S, Liu D, Sheng T, Thomas PE, Rabson AB, et al. Role of NF-kappaB in regulation of PXR-mediated gene expression: a mechanism for the suppression of cytochrome P-450 3A4 by proinflammatory agents. J Biol Chem 2006; 281: 17882-17889.
41. Chiu H, Brittingham JA, Laskin DL. Differential induction of heme oxygenase-1 in macrophages and hepatocytes during acetaminophen-induced hepatotoxicity in the rat: effects of hemin and biliverdin. Toxicol Appl Pharmacol 2002; 181: 106-115.
42. Ishida Y, Kondo T, Kimura A, Tsuneyama K, Takayasu T, Mukaida N. Opposite roles of neutrophils and macrophages in the pathogenesis of acetaminophen-induced acute liver injury. Eur J Immunol 2006; 36: 1028-1038.
43. Saito C, Yan H, Artigues A, Villar MT, Farhood A, Jaeschke H. Mechanism of protection by metallothionein against acetaminophen hepatotoxicity. Toxicol Appl Pharmacol 2010; 242: 182-190.
44. Rudd BD, Smit JJ, Flavell RA, Alexopoulou L, Schaller MA, Gruber A, et al. Deletion of TLR3 alters the pulmonary immune environment and mucus production during respiratory syncytial virus infection. J Immunol 2006; 176: 1937-1942.
45. Matsukura S, Kokubu F, Kurokawa M, Kawaguchi M, Ieki K, Kuga H, et al. Role of RIG-I, MDA-5, and PKR on the expression of inflammatory chemokines induced by synthetic dsRNA in airway epithelial cells. Int Arch Allergy Immunol 2007; 143( Suppl 1): 80-83.
46. Akira S. Pathogen recognition by innate immunity and its signaling. Proc Jpn Acad Ser B Phys Biol Sci 2009; 85: 143-156.
47. Giantonio BJ, Hochster H, Blum R, Wiernik PH, Hudes GR, Kirkwood J, et al. Toxicity and response evaluation of the interferon inducer poly ICLC administered at low dose in advanced renal carcinoma and relapsed or refractory lymphoma: a report of two clinical trials of the Eastern Cooperative Oncology Group. Invest New Drugs 2001; 19: 89-92.
48. Gillespie D, Hubbell HR, Carter WA, Midgette P, Elsasser W, Mullaney R, et al. Synergistic inhibition of AZT-resistant HIV by AZT combined with poly(I):poly(C12U), without synergistic toxicity to bone marrow progenitor cell elements. In Vivo 1994; 8: 375-381.
49. Cheng Y, Xu F. Anticancer function of polyinosinic-polycytidylic acid. Cancer Biol Ther 2011; 10: 1219-1223.